Public-private collaboration launches to tackle antibiotic research
New €224m (£180m) funding to enable development of antibiotics for bacterial infections and drive unprecedented information sharing
29-May-2012 -
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to ...
antibiotic resistance
antibiotics